COR— Cencora, Inc.

Health Care$63.7B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Revenue	$321.33T+9.3%	$293.96T+12.1%	$262.17T+9.9%	$238.59T
Cost of goods sold	$309.85T+9.1%	$284.05T+12.2%	$253.21T+10.0%	$230.29T
Gross profit	$11.48T+15.8%	$9.91T+10.6%	$8.96T+8.0%	$8.30T
Distribution, selling, and administrative	$6.49T+14.7%	$5.66T+6.6%	$5.31T+9.5%	$4.85T
Depreciation	$494.14B+15.3%	$428.50B+4.4%	$410.34B+6.1%	$386.60B
Amortization	$556.93B-16.1%	$663.47B+19.9%	$553.56B+80.1%	$307.30B
Litigation and opioid-related expenses (credit), net	$60.67B-73.3%	$227.07B+1019.6%	-$24.69B-120.0%	$123.19B
Acquisition-related deal and integration expenses	$291.04B+182.6%	$103.00B-26.3%	$139.68B+16.8%	$119.56B
Restructuring and other expenses	$229.42B-1.8%	$233.63B+1.6%	$229.88B+262.0%	$63.50B
Goodwill impairment	$723.88B+73.2%	$418.00B	$0-100.0%	$75.94B
Operating income	$2.63T+20.8%	$2.18T-7.1%	$2.34T-1.1%	$2.37T
Other loss (income), net	$78.72B+451.1%	$14.28B+129.1%	-$49.04B-79.3%	-$27.35B
Interest expense, net	$291.55B+85.7%	$156.99B-31.4%	$228.93B+8.7%	$210.67B
Income before income taxes	$2.26T+12.7%	$2.00T-7.3%	$2.16T-1.0%	$2.18T
Income tax expense	$690.52B+42.5%	$484.70B+13.2%	$428.26B-17.1%	$516.52B
Net income	$1.57T+3.2%	$1.52T-12.3%	$1.73T+4.0%	$1.67T
Net (income) loss attributable to noncontrolling interests	-$13.64B-34.4%	-$10.15B-179.8%	$12.72B-60.6%	$32.28B
Net income attributable to Cencora, Inc.	$1.55T+3.0%	$1.51T-13.5%	$1.75T+2.7%	$1.70T
Basic (in usd per share)	$8020.00+5.5%	$7600.00-11.8%	$8620.00+5.8%	$8150.00
Diluted (in usd per share)	$7960.00+5.7%	$7530.00-11.7%	$8530.00+6.1%	$8040.00
Basic (in shares)	193.8M-2.4%	198.5M-2.0%	202.5M-2.9%	208.5M
Diluted (in shares)	195.2M-2.5%	200.3M-2.1%	204.6M-3.1%	211.2M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 16 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.